NO20041300L - Flavanolignanpreparater med okt loselighet - Google Patents

Flavanolignanpreparater med okt loselighet

Info

Publication number
NO20041300L
NO20041300L NO20041300A NO20041300A NO20041300L NO 20041300 L NO20041300 L NO 20041300L NO 20041300 A NO20041300 A NO 20041300A NO 20041300 A NO20041300 A NO 20041300A NO 20041300 L NO20041300 L NO 20041300L
Authority
NO
Norway
Prior art keywords
flavanolignan
solubility
oct
compositions
approaches
Prior art date
Application number
NO20041300A
Other languages
English (en)
Norwegian (no)
Inventor
Kvetoslava Benesova
Ladislav Cvak
Milan Stuchlik
Original Assignee
Ivax Pharmaceuticals Sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Pharmaceuticals Sro filed Critical Ivax Pharmaceuticals Sro
Publication of NO20041300L publication Critical patent/NO20041300L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20041300A 2001-08-30 2004-03-29 Flavanolignanpreparater med okt loselighet NO20041300L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20013153A CZ292832B6 (cs) 2001-08-30 2001-08-30 Způsob přípravy silymarinu se zvýšenou rozpustností
PCT/US2002/027713 WO2003020291A1 (en) 2001-08-30 2002-08-30 Increased solubility flavanolignan preparations

Publications (1)

Publication Number Publication Date
NO20041300L true NO20041300L (no) 2004-03-29

Family

ID=5473538

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041300A NO20041300L (no) 2001-08-30 2004-03-29 Flavanolignanpreparater med okt loselighet

Country Status (15)

Country Link
US (1) US7384919B2 (enExample)
EP (1) EP1420802B1 (enExample)
JP (1) JP2005519863A (enExample)
KR (1) KR20040074052A (enExample)
CN (1) CN1582159A (enExample)
AT (1) ATE381340T1 (enExample)
AU (1) AU2002323517B2 (enExample)
CA (1) CA2458963A1 (enExample)
CZ (1) CZ292832B6 (enExample)
DE (1) DE60224202T2 (enExample)
MX (1) MXPA04001700A (enExample)
NO (1) NO20041300L (enExample)
NZ (1) NZ531429A (enExample)
TW (1) TWI238065B (enExample)
WO (1) WO2003020291A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005026755A1 (de) * 2005-06-09 2006-12-14 Basf Ag Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung
CN101969766B (zh) * 2007-10-17 2015-05-06 托德·F·奥沃凯泰斯 固态化合物的改良方法及使用其制备的共-无定形组合物
DE102008039271A1 (de) * 2007-12-23 2009-06-25 Euromed Sa Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung
CZ2008407A3 (cs) 2008-06-26 2009-08-26 Agra Group, A. S. Vodorozpustný prípravek na bázi flavanonol lignanu a zpusob jeho prípravy
JP5841048B2 (ja) * 2009-05-14 2016-01-06 エウロメッド・エセ・ア ウイルス性肝炎の治療のための非晶質シリビニン
US20120083013A1 (en) * 2009-05-19 2012-04-05 Suntory Holdings Limited Glucosyltransferase specific to position-4 of furofuran-type lignan, and polynucleotide encoding same
CN102228430B (zh) * 2011-06-14 2015-12-09 中国中医科学院中药研究所 水飞蓟宾磷脂复合物的纳米混悬剂及其制备方法
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
ITMI20121317A1 (it) * 2012-07-27 2014-01-28 Indena Spa Composizioni per il trattamento della fatica oncologica
JP2015113332A (ja) * 2013-12-16 2015-06-22 花王株式会社 生薬粉体
US10202598B2 (en) 2014-05-30 2019-02-12 Todd Frank Ovokaitys Methods and systems for generation, use, and delivery of activated stem cells
WO2015187974A1 (en) 2014-06-06 2015-12-10 Ovokaitys Todd Frank Methods and compositions for increasing the bioactivity of nutrients
US10384985B2 (en) 2014-06-06 2019-08-20 B.K. Consultants, Inc. Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants
JP6348024B2 (ja) * 2014-09-03 2018-06-27 株式会社ファンケル 水分散性の良いシリマリン含有組成物
KR101598752B1 (ko) * 2015-01-28 2016-02-29 순천향대학교 산학협력단 표면적 및/또는 다공성이 조절된 당알콜을 담체로 이용한 리포솜 조성물 및 그의 제조방법
ES2706008B8 (es) * 2017-09-22 2021-07-12 Euromed S A Procedimiento para la preparacion de una composicion a partir del cardo mariano y composicion obtenida
KR20230129426A (ko) 2020-12-08 2023-09-08 토드 프랭크 오보케이티스 줄기 세포 생산 증가를 위한 방법 및 시스템

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1554662A (en) * 1976-05-05 1979-10-24 Inverni Della Beffa Spa Polyhydroxyphenylchromanones
IT1215291B (it) * 1985-07-17 1990-01-31 Inverni Della Beffa Spa Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
US4767508A (en) * 1986-02-27 1988-08-30 Nippon Mining Co., Ltd. Strike plating solution useful in applying primer plating to electronic parts
IT1222012B (it) 1987-07-10 1990-08-31 Indena Spa Composizioni farmaceutiche e cosmetiche contenenti complessi di flavonolignani con fosfolipidi
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5019562A (en) * 1988-01-19 1991-05-28 The Trustees Of The University Of Pennsylvania/Childrens Hospital Corporation Growth inhibiting agent and the use thereof
IT1241673B (it) * 1989-10-09 1994-01-27 Istituto Biochimico Italiano Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
US5196448A (en) 1991-01-22 1993-03-23 Stiefel Laboratories, Inc. Antiinflammatory compositions and method of use
DE19501266A1 (de) * 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
CZ287657B6 (cs) 1996-06-12 2001-01-17 Mikrobiologický Ústav Av Čr Glykosidy silybininu a způsob jejich výroby
DE19744459A1 (de) 1997-10-08 1999-04-15 Schwabe Willmar Gmbh & Co Flavonolignan-Zubereitungen, insbesondere Silymarin-Zubereitungen

Also Published As

Publication number Publication date
JP2005519863A (ja) 2005-07-07
KR20040074052A (ko) 2004-08-21
CZ20013153A3 (cs) 2003-04-16
US20050101546A1 (en) 2005-05-12
TWI238065B (en) 2005-08-21
ATE381340T1 (de) 2008-01-15
CN1582159A (zh) 2005-02-16
DE60224202D1 (de) 2008-01-31
CA2458963A1 (en) 2003-03-13
CZ292832B6 (cs) 2003-12-17
DE60224202T2 (de) 2008-12-04
EP1420802B1 (en) 2007-12-19
AU2002323517B2 (en) 2009-12-10
NZ531429A (en) 2005-11-25
EP1420802A4 (en) 2005-02-09
EP1420802A1 (en) 2004-05-26
MXPA04001700A (es) 2005-04-11
WO2003020291A1 (en) 2003-03-13
US7384919B2 (en) 2008-06-10

Similar Documents

Publication Publication Date Title
NO20041300L (no) Flavanolignanpreparater med okt loselighet
TR200200068T2 (tr) Nematisital triflüorobütenler
DE60010098D1 (de) 28-epirapaloge
CY1110780T1 (el) Τοπικα σκευασματα νεπαφενακης
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
IS6040A (is) Valdekoxib efnablöndur
EA200200097A1 (ru) Имидазоимидазолы и триазолы в качестве противовоспалительных агентов
TR200100805T2 (tr) Tetrahidropiridoeterler
ATE231149T1 (de) (1,8)-naphthyridinderivate derivate mit antiviraler wirkung
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
BR0015490A (pt) Combinações oncolìticas para o tratamento de câncer
IL155263A0 (en) Pharmaceutical solutions of modafinil compounds
DE60021065D1 (de) Virus behandlung
ATE316102T1 (de) Peptide mit antiangiogener aktivität
NO20062699L (no) Smelteblandingsdispergeringer
ES2159287T3 (es) Peptidos hemorreguladores.
DK0544760T3 (da) Farmaceutiske præparater indeholdende 5-difluormethoxy-2- (3,4-dimethoxy-2-pyridyl)methylsulfinyl benzimidazol og at anti-helicobactermiddel til behandling af gastrointestinale lidelser
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
DK1131348T3 (da) Regulatoriske/udfoldende peptider af ezrin
DK1173194T3 (da) Rekombinant SP-A til behandlingen eller forebyggelsen af lungeinfektion og -inflammation
DE60011060D1 (de) Virus behandlung
FI930265A0 (fi) Antikoagulantpeptider

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application